Iaccarino, Guido

Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension.

Lembo, G., Napoli, R., Capaldo, B., Rendina, V, Iaccarino, G., Volpe, M., Trimarco, B., & Saccà, L. (1992) · Journal of Clinical Investigation

Blood Pressure and Hypertension StudiesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 252

Acute noradrenergic activation induces insulin resistance in human skeletal muscle

Lembo, G., Capaldo, B., Rendina, V., Iaccarino, G., Napoli, R., Guida, R., Trimarco, B., & Sacca, L. (1994) · American Journal of Physiology-Endocrinology and Metabolism

Diabetes, Cardiovascular Risks, and LipoproteinsMetabolism, Diabetes, and Cancer

Cited by 136

Exercise promotes angiogenesis and improves β-adrenergic receptor signalling in the post-ischaemic failing rat heart

Leosco, D., Rengo, G., Iaccarino, G., Golino, L., Marchese, M., Fortunato, F., Zincarelli, C., Sanzari, E., Ciccarelli, M., Galasso, G., et al. (2008) · Cardiovascular Research

Cardiovascular and exercise physiologyCardiac Fibrosis and Remodeling

Cited by 131

Physical Exercise: A Novel Tool to Protect Mitochondrial Health

Sorriento, D., Di Vaia, E., & Iaccarino, G. (2021) · Frontiers in Physiology

Mitochondrial Function and PathologyAutophagy in Disease and Therapy

Cited by 118

Modulation of Insulin Sensitivity by Exercise Training: Implications for Cardiovascular Prevention

Iaccarino, G., Franco, D., Sorriento, D., Strisciuglio, T., Barbato, E., & Morisco, C. (2021) · Journal of Cardiovascular Translational Research

Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular and exercise physiology

Cited by 106

Efficacy of cardiometabolic drugs in reduction of epicardial adipose tissue: a systematic review and meta-analysis

Myasoedova, V. A., Parisi, V., Moschetta, D., Valerio, V., Conte, M., Massaiu, I., Bozzi, M., Celeste, F., Leosco, D., Iaccarino, G., et al. (2023) · Cardiovascular Diabetology

Cardiovascular Disease and AdiposityAdipokines, Inflammation, and Metabolic Diseases

Cited by 93

Adrenergic receptors and metabolism: role in development of cardiovascular disease

Ciccarelli, M., Santulli, G., Pascale, V., Trimarco, B., & Iaccarino, G. (2013) · Frontiers in Physiology

Receptor Mechanisms and SignalingCardiovascular Function and Risk Factors

Cited by 89

The use of a telematic connection for the follow-up of hypertensive patients improves the cardiovascular prognosis

De Luca, N., Izzo, R., Iaccarino, G., Malini, P. L., Morisco, C., Rozza, F., Iovino, G. L., Rao, M. A. E., Bodenizza, C., Lanni, F., et al. (2005) · Journal of Hypertension

Blood Pressure and Hypertension StudiesHealthcare Systems and Technology

Cited by 80

Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor

Costa, B., Bendinelli, S., Gabelloni, P., Da Pozzo, E., Daniele, S., Scatena, F., Vanacore, R., Campiglia, P., Bertamino, A., Gomez-Monterrey, I., et al. (2013) · PLoS ONE

Cancer-related Molecular PathwaysGlioma Diagnosis and Treatment

Cited by 79

Parathyroid Hormone Causes Endothelial Dysfunction by Inducing Mitochondrial ROS and Specific Oxidative Signal Transduction Modifications

Gambardella, J., De Rosa, M., Sorriento, D., Prevete, N., Fiordelisi, A., Ciccarelli, M., Trimarco, B., De Luca, N., & Iaccarino, G. (2018) · Oxidative Medicine and Cellular Longevity

Nitric Oxide and Endothelin EffectsParathyroid Disorders and Treatments

Cited by 58

GRKs and β-Arrestins: “Gatekeepers” of Mitochondrial Function in the Failing Heart

Sorriento, D., Gambardella, J., Fiordelisi, A., Iaccarino, G., & Illario, M. (2019) · Frontiers in Pharmacology

Mitochondrial Function and PathologyReceptor Mechanisms and Signaling

Cited by 16